---
title: "\"Performance\" CONSUN PHARMA's annual net profit is RMB 1.078 billion, an increase of 18.4%, with a final dividend of HKD 0.4"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280563722.md"
description: "CONSUN PHARMA announced its full-year results for the year ended last December, with revenue of RMB 3.417 billion, an increase of 15.2% year-on-year. Net profit was RMB 1.078 billion, an increase of 18.4% year-on-year; earnings per share were RMB 1.27. A final dividend of HKD 0.4 was declared, compared to HKD 0.3 in the same period last year"
datetime: "2026-03-26T04:00:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280563722.md)
  - [en](https://longbridge.com/en/news/280563722.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280563722.md)
---

# "Performance" CONSUN PHARMA's annual net profit is RMB 1.078 billion, an increase of 18.4%, with a final dividend of HKD 0.4

CONSUN PHARMA (01681.HK) announced its full-year results for the year ended December last year, with revenue of RMB 3.417 billion, an increase of 15.2% year-on-year. Net profit was RMB 1.078 billion, an increase of 18.4% year-on-year; earnings per share were RMB 1.27. A final dividend of HKD 0.4 was declared, compared to HKD 0.3 in the same period last year

### Related Stocks

- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [562050.CN](https://longbridge.com/en/quote/562050.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [01681.HK](https://longbridge.com/en/quote/01681.HK.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)

## Related News & Research

- [Grand Pharmaceutical Moves to Adopt New Bye-Laws Aligned With HK Paperless Regime](https://longbridge.com/en/news/284576690.md)
- [CSPC Innovation Posts Strong Revenue Growth but Wider Losses in Q1 2026](https://longbridge.com/en/news/284213122.md)
- [GenFleet Asserts Independent IP for Pan RAS Inhibitor GFH276 Amid Sector Dispute](https://longbridge.com/en/news/284312081.md)
- [Junshi Biosciences Shareholder Plans Up to 2% Stake Reduction](https://longbridge.com/en/news/283841816.md)
- [ZAWYA: Emirates Drug Establishment approves first nasal epinephrine spray as alternative to injections for severe allergic reaction](https://longbridge.com/en/news/284603051.md)